34 studies found for:    " August 20, 2008":" September 19, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Affect Management Intervention for Early Adolescents Wtih Mental Health Problems
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
22 Terminated TMC278-TiDP15-C150: Trial to Examine Safety, Tolerability and Plasma Pharmacokinetics of Multiple Doses of TMC278LA.
Condition: HIV-1
Intervention: Drug: TMC278
23 Completed Efficacy of Influenza Vaccine in HIV Infected Adults
Conditions: HIV;   Influenza;   Vaccination;   HIV Infections
Intervention: Biological: MUTAGRIP
24 Active, not recruiting Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
Conditions: HIV;   Hepatitis C;   Infections
Intervention: Drug: Pegylated interferon alfa and ribavirin (PEG-IFN/RBV)
25 Active, not recruiting Rollover Study Protocol for Pediatric Patients in South Africa for Continued Access to Emtricitabine
Condition: HIV-1 Infection
Intervention: Drug: Emtricitabine
26 Completed
Has Results
A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen
Conditions: Virus Diseases;   HIV
Intervention: Drug: Switch NRTIs as a Backbone to Raltegravir
27 Completed TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.
Conditions: HIV;   AIDS
Intervention: Drug: Darunavir
28 Completed TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.
Condition: HIV
Intervention: Drug: TMC278
29 Completed TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women.
Conditions: HIV;   AIDS;   Oral Contraceptive
Intervention: Drug: TMC278
30 Unknown  Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
Condition: HIV Infections
Intervention: Drug: Raltegravir and Atazanavir
31 Completed Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART
Condition: HIV Infections
Intervention:
32 Completed
Has Results
Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.
Conditions: HIV Infections;   HSV-2 Genital Herpes
Intervention: Drug: 3% SPL7013 Gel (VivaGel)
33 Terminated
Has Results
Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)
Condition: Progressive Multifocal Leukoencephalopathy
Intervention: Drug: mefloquine
34 Completed Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Conditions: Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Other: educational intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-34) Next Page   
Indicates status has not been verified in more than two years